REDIDOSE

pharmaceutical preparations and substances for the treatment of gastrointestinal disorders; and for use in the treatment of duodenal ulcer, gastric ulcer pathological hypersacretory condition such as Zollinger-Ellison syndrome and system mastocytosis, gastroesophageal reflux disease on erosive esophagitis and in the prevention of duodenal ulcer